Lumiera Health Inc. announced a private placement of up to 60,000,000 units at an issue price of CAD 0.01 per unit for proceeds of CAD 600,000 on November 18, 2022. Each Unit will consist of one common share and one common share purchase warrant, with each Warrant entitling the holder to acquire one additional Common Share, at an exercise price of CAD 0.05 per share, for a period of three years from the date of issuance. The Company intends to include an acceleration clause in the certificates representing the Warrants whereby the Company may accelerate the expiry of these Warrants at any time prior to the expiry date in the event the daily volume weighted average trading price of the Common Shares of the Company on the TSX Venture Exchange exceeds CAD 0.08 for at least 10 consecutive trading days by providing written notice to the warrant holders.

At the Closing Date, the Company may pay to finders a commission equal to 7.5% of the gross proceeds from the sale of Offered Securities. The offering is expected to close on or before December 16, 2022.